Type of security: Stock
Sector: Health Care
Industry: Medical/Dental Instruments
The data is delayed by 15 minutes.
Description: Amedica Corporation, a commercial-stage biomaterial company, develops, manufactures, and sells a range of medical devices in the United States. It offers Valeo silicon nitride interbody spinal fusion devices for use in the cervical and thoracolumbar areas of the spine; Valeo stand-alone anterior lumbar intervertebral fusion device; and a line of non-silicon nitride spinal fusion products used by surgeons to promote bone growth and fusion in spinal fusion procedures. The company also develops femoral heads for use in its total hip replacements; and femoral condyle components for use in its total knee replacements. It markets and sells its products to surgeons and hospitals in the United States, Europe, and South America through a network of independent sales distributors. The company has research and development agreement with Kyocera Industrial Ceramics Corporation to manufacture silicon nitride-based spinal fusion products and product candidates. Amedica Corporation was founded in 1996 and is headquartered i
|Shares Outstanding||EPS||-1.43||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||-18.73%||Sales Growth - Q/Q||-7.92%||P/E||-0.22|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||-76.16%||ROE||-1045.27%||ROI||-169.04%|
|Current Ratio||1.28||Quick Ratio||0.81||Long Term Debt/Equity||2.47||Debt Ratio||7.38|
|Gross Margin||64.18%||Operating Margin||-111%||Net Profit Margin||-153.03%||Dividend Payout Ratio|
|Cash From Financing Activities||-120 K||Cash From Investing Activities||-270 K||Cash From Operating Activities||-2.97 M||Gross Profit||3.22 M|
|Net Profit||-5.38 M||Operating Profit||-4.1 M||Total Assets||43.66 M||Total Current Assets||30.11 M|
|Total Current Liabilities||23.49 M||Total Debt||22.27 M||Total Liabilities||40.48 M||Total Revenue||4.74 M|
|High 52 week||3.42||Low 52 week||0.17||Last close||0.23||Last change||9.22%|
|RSI||54.98||Average true range||0.02||Beta||0.12||Volume||212.16 K|
|Simple moving average 20 days||6.22%||Simple moving average 50 days||3.86%||Simple moving average 200 days||-59.49%|
|Performance Week||13.81%||Performance Month||4.65%||Performance Quart||-10.36%||Performance Half||-52.13%|
|Performance Year||-92.77%||Performance Year-to-date||25%||Volatility daily||4.92%||Volatility weekly||11%|
|Volatility monthly||22.55%||Volatility yearly||78.12%||Relative Volume||268.27%||Average Volume||203.2 K|
|New High||New Low|
2019-01-03 09:00:00 | SINTX ANNOUNCES 30-YEAR SPINE FUSION DATA WITH SILICON NITRIDE IMPLANTS
2018-10-31 09:00:00 | AMEDICA ANNOUNCES CORPORATE NAME CHANGE TO SINTX TECHNOLOGIES, INC.
2018-10-03 09:00:00 | AMEDICA ANNOUNCES CLOSING OF THE SALE OF ITS SPINE BUSINESS TO CTL MEDICAL
2018-09-26 08:10:00 | Amedica Agrees to Sell its Commercial Spine Products Business, Analyst Coverage
2018-09-25 08:00:34 | DFW company makes key acquisition that started with a cold call
2018-09-06 09:00:00 | AMEDICA ANNOUNCES AGREEMENT TO SELL SPINE BUSINESS TO CTL MEDICAL
2018-07-24 07:45:00 | Complimentary Technical Snapshots on PAVmed and Three More Medical Equipment Stocks
2018-06-27 07:10:00 | Initiating Free Research Reports on Avinger and Three Other Medical Equipment Equities
2018-06-04 15:06:20 | How Financially Strong Is Amedica Corporation NASDAQ:AMDA?
2018-05-24 07:05:00 | Abbott Labs and Three Additional Medical Equipment Stocks on Our Research Desk’s Radar
2018-05-08 09:30:00 | Amedica Corporation Provides Update on its Clinical Studies
2018-04-10 11:43:17 | What Should You Know About Amedica Corporation’s NASDAQ:AMDA Growth?
2018-03-30 09:00:00 | Amedica Announces Patent Grant for Silicon Nitride and Other Ceramic Materials
2018-03-26 16:58:15 | Does Amedica Corporation’s NASDAQ:AMDA Latest Financial Perfomance Look Strong?
2018-03-15 09:00:00 | Amedica Granted Extension by NASDAQ to Regain Compliance with NASDAQ Listing Rule
2018-03-06 09:00:00 | Amedica announces FDA Clearance of the Valeo C+CSC with Lumen Interbody Fusion Device
2018-02-27 09:00:00 | AMEDICA Announces Participation in Australian Spine Conference
2018-01-25 09:00:00 | AMEDICA PROVIDES BUSINESS UPDATE
2017-12-15 12:51:01 | ETFs with exposure to Amedica Corp. : December 15, 2017
2017-12-05 12:17:54 | ETFs with exposure to Amedica Corp. : December 5, 2017
2017-12-01 09:00:00 | Amedica Receives Positive Nasdaq Listing Decision
2017-12-01 08:10:37 | Amedica Corp. :AMDA-US: Earnings Analysis: Q3, 2017 By the Numbers : December 1, 2017
2017-11-21 07:59:11 | Breaking Down Amedica Corporation’s AMDA Ownership Structure
2017-11-21 06:50:00 | Amedica Corp. to Host Earnings Call
2017-11-15 07:57:07 | Does Amedica Corporation’s AMDA Debt Level Pose A Serious Problem?
2017-11-10 09:00:00 | Amedica Announces Reverse Stock Split
2017-11-06 09:00:00 | Amedica Submits 510k Application to FDA for Valeo C+CSC with Lumen
2017-10-23 09:00:00 | Amedica Announces Podium Presentations and Participation at NASS 2017
2017-10-17 09:00:00 | Amedica Receives Positive Nasdaq Listing Decision
2017-10-03 10:25:56 | Amedica Announces Adjournment of Special Meeting of Stockholders
2017-09-27 09:00:00 | Amedica Announces Adjournment of Special Meeting of Stockholders
2017-09-07 09:00:00 | Amedica Announces Adjournment of Special Meeting of Stockholders
2017-08-25 17:00:00 | Amedica Receives Nasdaq Listing Determination; Plans to Request Hearing
2017-08-14 16:30:00 | Amedica Announces Adjournment of Special Meeting of Stockholders
2017-06-22 09:00:00 | Is Amedica a Value Proposition at These Levels?
2017-06-08 09:00:00 | Amedica Releases 2016 Preliminary Earnings Report and Business Update